Oncopeptides hosts a virtual symposium at the 25[th] European Hematology Association Congress on Challenges in Managing Patients with Myeloma
STOCKHOLM — June 11, 2020 — Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today that the Company hosts a symposium at the EHA 25 Virtual Edition on June 13[th], focusing on the “Challenges in Managing Patients with Myeloma”. A panel of international experts will discuss disease assessment and treatment options in myeloma and share clinical experiences of managing patients that are difficult to treat.Due to the COVID-19 pandemic, the annual hematology meeting will be virtual. Oncopeptides has developed a virtual booth to demonstrate its commitment to the multiple myeloma community,